JPRN-UMIN000000484已完成1 期
Phase I/II Study of S-1, Cisplatin and Docetaxel in Patients with Advanced Gastric Cancer - Phase I/II Study of S-1, Cisplatin and Docetaxel in Patients with Advanced Gastric Cancer
Department of Gastroenterology and Hematology, Faculty of Medicine, University of Toyama0 个研究点目标入组 40 人开始时间: 2006年9月11日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Active other malignancy 2) Interstitial pneumonitis, pulmonary fibrosis 3) Massive pleural effusion or massive ascites 4) Active infection 5) Watery diarrhea 6) Other uncontrolled severe illness 7) Brain metastases 8) Pregnant or lactating women 9) Not appropriate for the study at the physician's assessment
研究者
相似试验
已完成
1 期
Phase I study of Docetaxel, Cisplatin and S-1 in patients with advanced or recurrent gastric cancerGastric cancerJPRN-UMIN000000978Shizuoka Cancer Center18
招募中
2 期
Phase II study of DCS-Tgastric cancerJPRN-jRCTs061180096Takayama Tetsuji30
招募中
不适用
Phase 2 study of S-1, docetaxel, cisplatin and trastuzumab combination chemotherapy (DCS-T) in patients with HER2-positive unresectable metastatic gastric cancergastric cancerJPRN-UMIN000012042Tokushima-Hokkaido cancer therapy clinical trial group30
招募中
1 期
DOS studygastric cancerJPRN-jRCTs061180095Takayama Tetsuji30
招募中
不适用
Phase I/II study of S-1, docetaxel, oxaliplatin combination chemotherapy (DOS) in patients with HER2-negative unresectable metastatic gastric cancergastric cancerJPRN-UMIN000015849Department of Gastroenterology and Oncology59